The ImPACT program organized by the cabinet office of Japan started to develop 3D real-time photoacoustic imaging technology which is applicable for wider clinical filed based on the philosophy of "Vascular Health Science" and inspection of industry materials.
Introduction
Photoacoustic (PA) imaging combines optical and ultrasound imaging and provides merits of both imaging technologies. In particular, it provides high optical contrast sensitivity to important physiological parameters such as the oxygen saturation of hemoglobin. PA imaging offers better spatial resolution of ultrasound for deep imaging compared with purely optical imaging. In addition, PA imaging involves ultrasound detection, so it is mostly suitable for multimodality diagnosis with ultrasound imaging that can provide structural information overlaid with functional PA imaging. Owing to the capability of structural, functional, and molecular imaging in vivo, PA imaging has been explored for the early diagnosis of cancer, the imaging of tumor angiogenesis, and identification of cardiovascular plaques. To expand applications of photoacoustic imaging to wider clinical fields, healthcare and non-medical purposes, we are promoting a research and development program referred to as the ImPACT program with support from the cabinet office of Japan.
Clinical translation of PA imaging
Prior to the ImPACT program, we developed a photoacoustic mammography (PAM) system in Kyoto University/Canon joint research project "Innovative Techno-hub for Integrated Medical Bio-imaging" supported by MEXT from 2006. A first prototype of PAM employed a dual illuminated mode photoacoustic tomography system. The breast is mildly compressed between holding plates. Pulsed laser beams irradiate the breast from both sides, and photoacoustic signals are detected on the caudal side by an array transducer, at the same time as the ultrasound image [1] . Recently, a revised prototype with hemispherical sensors was developed to improve the visibility of vessels, and its clinical evaluation is currently underway.
To achieve the practical use of a PA imaging system in clinical applications, we have to challenge the following many problems.
1) High-resolution, high-speed imaging 2) Sufficient imaging quality in deep tissue 3) Quantification Rapid examination and point of care require simultaneous pursuit of high-resolution and high-speed imaging. However, in practice, it is difficult to satisfy both requirements due to the cost and fabrication, resulting in reconstruction with artifacts or long data acquisition times for scanning [2] .
In clinical use, an image reconstruction method focusing on low SNR conditions is especially important to improve imaging quality in deep tissue due to less illumination and decay of ultrasound signals. However, many factors (unknown ultrasound velocity, clutter noise, movement of target, etc.) degrade the performance of the reconstruction methods to recover images from weak and noisy signals.
For high-quality functional imaging, such as blood oxygen saturation and tissue characterization, quantification of signals is greatly important [3] . Quantitative PA imaging requires knowledge of the local optical fluence and absorption monitored at the same location with multiple wavelengths. However, due to the optical heterogeneities in tissue, quantification of local fluence is challenging.
Development of innovative photoacoustic imaging technology
To expand applications of photoacoustic imaging technology, the ImPACT (Impulsing Paradigm Change through Disruptive Technology) program (Program Manager: Takayuki Yagi), "Innovative visualization technology to lead to creation of a new growth industry," started with support from the cabinet office of Japan in 2014. The objective of the program is to develop a new 3D visualization technology based on photoacoustic imaging that can image the state of the human body non-invasively and material objects non-destructively, to enable early diagnosis of diseases and inspection of industrial materials in order to contribute to safety and security.
The program is conducted through several projects covering (1) the base technologies about visualization using photoacoustic technology, (2) tunable lasers adapted to the absorption spectrum of the human body and substances, (3) ultrasound sensor arrays with high bandwidth and high sensitivity, (4) visualization system development, and (5) evaluation of the availability in the medical and quality examination field.
Biomedical imaging is still the main target in the ImPACT program. The 3D real-time PA imaging system shown in Fig. 1 is planned to be developed. It is applicable for wider clinical fields: cancer diagnosis, orthopedics, dermatology, plastic surgery, and dementia as shown in Fig. 2 , as well as health and beauty care. In addition, we aim to foster "Vascular Health Science," a new health science to contribute to the early prediction of diseases and health maintenance by monitoring blood vessel networks and blood state in the human body to enable people to continue working while preserving their health and beauty in the super-aging society.
Conclusions
Although the above focuses on medical applications, the ImPACT program aims to grow new industry based on PA technology: a new medical imaging industry, a new healthcare and beauty industry and a new measurement industry for security and safety inspection, with applications in quality inspections for foods and industrial products, etc. As mentioned above, there are many challenges with clinical translation of PA imaging, but we expect they can be overcome by our collaboration.
